gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with bumetanide in 1 studies
| Studies (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Trials (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Recent Studies (post-2010) (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Studies (bumetanide) | Trials (bumetanide) | Recent Studies (post-2010) (bumetanide) |
|---|---|---|---|---|---|
| 638 | 31 | 243 | 2,033 | 150 | 354 |
| Protein | Taxonomy | gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate (IC50) | bumetanide (IC50) |
|---|---|---|---|
| Solute carrier family 12 member 2 | Homo sapiens (human) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haaga, J; Jin, E; Lu, ZR; Malamas, AS; Zhang, Q | 1 |
1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and bumetanide
| Article | Year |
|---|---|
Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model.
Topics: Angiogenesis Inhibitors; Animals; Bumetanide; Capillary Permeability; Cell Line, Tumor; Colonic Neoplasms; Contrast Media; Cyclohexanes; DEET; Gadolinium DTPA; Heterocyclic Compounds; HT29 Cells; Humans; Macromolecular Substances; Magnetic Resonance Imaging; Mice; Mice, Nude; Neovascularization, Pathologic; Organometallic Compounds | 2015 |